Showing 1 - 6 results of 6 for search 'V. N. Amirjanova', query time: 0.03s Refine Results
  1. 1
    Dynamics of patient reported outcomes during the use various biological disease-modifying antirheumatic drugs for rheumatoid arthritis

    Dynamics of patient reported outcomes during the use various biological disease-modifying antirheumatic drugs for rheumatoid arthritis by A. E. Karateev, A. M. Lila, T. S. Panevin, A. S. Potapova, A. S. Semashko, A. O. Bobkova, V. N. Amirjanova, E. G. Zotkin

    Published 2022-09-01
    Get full text
    Article
  2. 2
    The use of biological disease-modifying antirheumatic drugs and Janus kinase inhibitors in rheumatoid arthritis during the COVID-19 coronavirus disease pandemic: data from a telephone survey of 254 patients

    The use of biological disease-modifying antirheumatic drugs and Janus kinase inhibitors in rheumatoid arthritis during the COVID-19 coronavirus disease pandemic: data from a teleph... by A. E. Karateev, E. Yu. Polishchuk, A. S. Potapova, E. V. Matyanova, A. S. Semashko, А. O. Bobkova, E. S. Filatova, V. N. Amirjanova, S. I. Glukhova, E. G. Zotkin, A. M. Lila

    Published 2022-05-01
    Get full text
    Article
  3. 3
    The first experience of using upadacitinib in the treatment of rheumatoid arthritis in real clinical practice (results of the multicenter project “RACURS”)

    The first experience of using upadacitinib in the treatment of rheumatoid arthritis in real clinical practice (results of the multicenter project “RACURS”) by V. N. Amirjanova, A. E. Karateev, E. Y. Pogozheva, A. A. Baranov, V. I. Mazurov, R. R. Samigullina, O. N. Anoshenkova, N. A. Lapkina, T. Yu. Grineva, E. L. Nasonov, A. M. Lila

    Published 2021-10-01
    Get full text
    Article
  4. 4
    Are the goals of therapy achievable in patients with rheumatoid arthritis receiving upadacitinib in real clinical practice?

    Are the goals of therapy achievable in patients with rheumatoid arthritis receiving upadacitinib in real clinical practice? by V. N. Amirjanova, A. E. Karateev, E. Yu. Pogozheva, E. S. Filatova, R. R. Samigullina, V. I. Mazurov, O. N. Anoshenkova, N. A. Lapkina, A. A. Baranov, T. Yu. Grineva, A. M. Lila, E. L. Nasonov

    Published 2022-07-01
    Get full text
    Article
  5. 5
    Factors affecting the results of analgesic therapy. Results of the Russian multicentre study of NOTE (NSAID: Open-label Trial of Efficacy)

    Factors affecting the results of analgesic therapy. Results of the Russian multicentre study of NOTE (NSAID: Open-label Trial of Efficacy) by A E Karateev, E Yu Pogozheva, E A Filatova, V N Amirjanova, A M Lila, O V Antipova, A R Babaeva, A V Volkorezova, A F Davydova, V G Davtyan, E V Zonova, O N Ivanova, N N Kalinina, N I Kiseleva, L A Knyazeva, A I Kulikov, O B Nesmeyanova, V I Mazurov, L V Masneva, L V Menshikova, I V Obuhova, E N Otteva, T S Salnikova, I N Shchendrygin, S P Yakupova

    Published 2018-06-01
    Get full text
    Article
  6. 6
    Evaluation of the effectiveness of Tofacitinib in rheumatoid arthritis in real clinical practice: The relationship between pain relief in the first 4 weeks and disease activity after 3–6 months

    Evaluation of the effectiveness of Tofacitinib in rheumatoid arthritis in real clinical practice: The relationship between pain relief in the first 4 weeks and disease activity aft... by A. E. Karateev, E. Yu. Pogozheva, V. N. Amirjanova, E. S. Filatova, A. M. Lila, V. I. Mazurov, R. R. Samigullina, A. M. Dadalova, A. Yu. Dyo, D. S. Chakieva, A. A. Baranov, N. A. Lapkina, E. N. Koltsova, N. A. Kiryukhina, I. N. Shchendrigin, T. G. Rasevich, A. F. Davydova, I. V. Semizarova, I. A. Shafieva, I. B. Bashkova, D. A. Bobrikova, D. A. Murtazalieva, I. N. Kushnir, E. V. Kalinina, T. S. Salnikova, I. M. Marusenko, O. V. Semagina, I. B. Vinogradova, D. G. Krechikova, M. Yu. Semchenkova, E. L. Nasonov

    Published 2021-09-01
    Get full text
    Article

Search Tools: